Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines
In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke.
In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental, and social data) started notifying consenting study participants who have certain genetic variants that predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality.
Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care.
“Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study.
“Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at-risk individuals.”
Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease-relevant to their underlying genetic condition.
“We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.”
Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions.
“For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be lifechanging.”
According to the CDC, early detection and intervention of Tier 1 genetic conditions could have a meaningful potential for clinical actionability and a positive impact on public health.
The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- COVID-19: Genetic Testing Market 2020-2024 | Rising Approval of Advanced Genetic Testing Products to boost Market Growth | Technavioon September 4, 2020 at 11:02 am
Technavio has been monitoring the genetic testing market and it is poised to grow by USD 4.86 billion during 2020-2024, progressing at a CAGR of over 12% during the forecast period. The report offers ...
- Strength Seen in Fulgent Genetics (FLGT): Stock Soars 11.6%on September 4, 2020 at 8:16 am
Fulgent Genetics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. A better-ranked stock in the Medical Info Systems industry is NextGen Healthcare, Inc. NXGN, which currently ...
- Identification of disease-causing variants by comprehensive genetic testing with exome sequencing in adults with suspicion of hereditary FSGSon September 4, 2020 at 4:25 am
Genetic data on adult patients are scarce with low diagnostic yields. Exome sequencing (ES) was performed in patients with adult disease onset and a high likelihood for hereditary FSGS. A high ...
- INTERVIEW: Phosphorus Covid-19 Testing Scales Up Along With Genetics Businesson September 3, 2020 at 10:52 am
Phosphorus CEO Alex Bisignano By Jarrett Banks The genomics-as-a-service model was flying high before the Covid-19 pandemic. But Phosphorus Chief Executive Officer Alex Bisignano couldn’t sit still. T ...
- Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate canceron September 3, 2020 at 5:02 am
PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced enrollment has begun for a ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Community-based genetic screening
- OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Teston September 3, 2020 at 2:49 pm
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its ORAcolle ...
- Coronavirus updates: CDC warns vaccine supply could be limited at first; Dow recovers 2020 losseson August 29, 2020 at 1:58 pm
The coronavirus has infected more than 24.56 million people around the world so far, killing at least 833,508 people.
- Researchers Announce 'Likely' Case Of Reinfection In Reno Man Hospitalized For COVID-19, First In U.s.on August 28, 2020 at 1:19 pm
According to the researchers' findings, a 25-year-old patient from Reno tested positive for COVID-19 at a community-based testing event ... that they have "degree of genetic discordance that ...
- LA Hospital Seeks Vaccine Trial Participants Among Its Own High-Risk Patientson August 28, 2020 at 9:16 am
UCLA wants to recruit most, if not all, of the trial's 500 participants from among people over 65, those with chronic illnesses and members of underserved racial and ethnic groups.
- Louisiana Extends Virus Restrictions for Two Weeks as Hurricane Laura Approacheson August 26, 2020 at 2:03 pm
"We're basically going to be blind for this week because we'll have to discontinue much of our community-based testing," Mr. Edwards ... researchers who conducted a genetic analysis found that ...